People

Dr. Emad Al Thukair is the Global CEO of InterHealth Canada Ltd. and Chairman of the Saudi British Joint Council, bringing over 35 years of international healthcare and business expertise to these roles. A Fellow of the Royal College of Obstetricians and Gynecologists (London), he began his career as a medical practitioner before expanding into healthcare management and entrepreneurship. Dr. Al Thukair founded the El Dukair Medical Center in Riyadh in 1984 and has, through his partnership in InterHealth Canada Limited, become a leading figure in developing Public-Private Partnership (PPP) solutions for healthcare delivery globally. His expertise in integrating financing, infrastructure development, and clinical services has proven invaluable in his current leadership positions. Throughout his career, he has held advisory positions with various prestigious organizations, including the Commonwealth Enterprise and Investment Council in the UK, and is currently a board member of UCL Global Healthcare Business College and the Qatar University Healthcare Advisory Board. Dr. Al Thukair's unique combination of clinical background, business acumen, and international experience positions him as a distinguished leader in global healthcare management and development.

Emad Al Thukair on LinkedIn

Martin had a distinguished career with 8 years in investment banking & over 28 years in management consulting with KPMG. He was chairman of KPMG NSW for 8 years, Australian leader for the firm’s financial services practice for 4 years, leader of the insurance practice for 5 years, established the firm’s global fintech insurance community and played a key role in establishing Stone & Chalk, the first Fintech Centre in Australia and was lead partner for NSW Government for 5 years from 2017 to 2021. During his time as senior partner in management consulting at KPMG, Martin worked with clients across the private and public sectors and led a wide range of transformation projects in Australia and Asia.

Martin established an executive coaching business, iHelm, in 2021, where he applies his passion, expertise and knowledge to improve business performance through people, working with senior executives to help them achieve their business and personal goals. He joined SM Group as an executive coach and Chairman of the Advisory Board in April 2024. Martin has coupled his extensive business experience to his strong commitment to supporting better community outcomes. He has served on a number of NFP Boards, including Chairing the Advisory Board for the University of Sydney Business School for 8 years, Chair Risk & Audit Committee for the Committee for Sydney Board for 12 years, the Advance board for 8 years and the President’s Council for the NSW Art Gallery for 7 years. He is currently the Chair for the Groundswell Foundation.

Martin founded the Groundswell Foundation in 2021 to address the growing issue of loneliness and its impact on mental health in Australia. Loneliness is considered by many to be one of the most profound and rapidly developing social issues in the world today, particularly when its relationship to mental health and connected communities is considered.

Martin Blake on LinkedIn

Ann is a senior healthcare leader with over 30 years’ experience in the Pharmaceutical and MedTech Industry. She started her pharmaceutical career with Merck, Sharp and Dohme Limited and has held numerous commercial and partnership roles with responsibility for a range of product portfolios. Ann currently leads Baxter Healthcare’s Government Affairs and Market Access agenda, where she is tasked with managing key policies impacting the HealthTech sector and the NHS, supporting change that enables the adoption and spread of innovations that deliver whole-system value across healthcare settings. She has a strong history of developing partnerships and driving transformation across multiple settings. She is passionate about bringing real change to health with broad experience in establishing trusted relationships to develop meaningful solutions.

Ann Cole on LinkedIn

Vanessa is the Managing Director of Clinical Services International (CSI), a leading biopharmaceutical service provider of clinical trial supplies. With over 20 years of experience in drug development, market access, and commercialization, she leads a team of experts who offer a fully integrated service for comparator sourcing, reference listed drugs, regulatory advice, and supply chain management.

As a scientist-entrepreneur, Vanessa has a passion for advancing immuno-oncology studies with world-leading access to branded medicines, generics, and biosimilars. She has secured product registration for several orphan and first-in-class drugs, and has worked with some of the largest biopharmaceutical and biotech companies to provide innovative solutions. She is also a board member at Cambridge Judge Business School, a fellow at Royal Society of Medicine, and an advisor to Chelsea & Westminster Hospital. Vanessa holds a PhD in Cardiovascular Genetics from UCL, an MBA from Cambridge, and a Masters in Market Access from University of Lyon.

Vanessa Dekou on LinkedIn

Eva McLellan is a global health executive and purpose-driven leader with 18 years of experience at the nexus of science, leadership, and innovation within the biotechnology sector. She has held senior leadership roles across Canada, Europe, and Switzerland at Roche. Currently, Eva leads the worldwide end-to-end commercialization strategy for Roche’s Cardiovascular, Renal, and Metabolism portfolio, driving transformative impact on global patient outcomes.

Beyond her corporate leadership, Eva co-founded Unlocking Eve, a Swiss-based foundation dedicated to reimagining integrated leadership through a systems lens and cultivating future leaders. She has published multiple white papers on integrated leadership and healthcare systems transformation and is a sought-after thought partner and advisor. Eva leads with clarity and empathy—navigating complexity with a rare blend of strategic rigor and human-centered focus..

Eva serves on the World Economic Forum’s Global Future Council on Leadership and is an Adjunct Professor at the University of Toronto. Recognized among Canada’s Top 20 Under 40 in Life Sciences in 2024, and a Fellow of the Young Global Leaders Forum (WEF), she holds a Master’s in Biotechnology from the University of Toronto and completed Executive General Management education at INSEAD. Eva brings advisory and governance experience, fostering collaboration among global stakeholders to accelerate innovation and lasting impact.

Eva McLellan on LinkedIn

Chris Outram is a strategy consultant with a career spanning over five decades. He co-founded OC&C Strategy Consultants in 1987, a leading global firm, and served as its Chairman Emeritus. He has held leadership roles at Booz Allen & Hamilton, Van Gelder Papier, and the Boston Consulting Group. Outram's educational background includes a Double First-Class degree from Birmingham University and an MBA with Distinction from INSEAD. He has also chaired various organisations and is involved in advisory roles, including the UCL Global Business School for Health​

Chris Outram on LinkedIn

David is an accomplished medical doctor, entrepreneur, and global board member with extensive experience in healthcare innovation and strategic growth in emerging markets. He has advised multiple global businesses over the past five years, leveraging his expertise in corporate governance and market-entry strategies. David’s work spans across the US, UK, and four continents, where he has led complex initiatives such as mergers and acquisitions, strategic turnarounds, IPOs, and the introduction of new healthcare technologies.

As the founder of Novamed, the leading healthcare investment firm in the Caribbean, David has driven significant advancements in the region, including the development of Jamaica’s largest smart city business campus. Under his leadership, Novamed’s portfolio has expanded to include hospitals, clinics, and a venture arm that launched the Caribbean’s first healthcare accelerator and innovation lab in collaboration with the IDB and Rock Health.

David’s global influence is further evidenced by his role as a founding partner of the Visionaries Summit, where he helped create an investment platform that has seeded over $300 million across various sectors in the Caribbean. His leadership was recognized in 2021 when he was honoured as a World Economic Forum Young Global Leader and Global Future Council member. David’s academic background includes a Rhodes Scholarship and advanced degrees from Oxford, INSEAD, and executive education from Harvard, Wharton, and NTU. His work has been featured in prestigious publications such as Forbes, Financial Times, and The Economist.

David Walcott on LinkedIn

Michael is the Global Lead for Health and Care Workforce Solutions at KPMG, overseeing initiatives in 38 countries to address workforce shortages.

He leads KPMG's Health and Human Services Consulting Team in the UK and has worked on major projects, including workforce models for the NHS Nightingale hospitals during COVID-19 and the System Workforce Improvement Model, which informed the NHS People Plan. Michael advises the Department of Health & Social Care on workforce reform and helped establish the Centre for Workforce Development in Bradford and the Leeds Health & Care Academy. He has 11 years of NHS experience, including roles as Head of Primary Care and NHS LIFT Director for Leeds. Michael is also a visiting lecturer at UCL and a Non-Executive Director at Age UK (Leeds).

Dr Dominique Allwood is the Chief Executive Officer of Imperial College Health Partners, with over 20 years of experience in healthcare leadership, innovation, and policy-making. She has held key roles, including Chief Medical Officer at UCLPartners and Director of Population Health at Imperial College Healthcare NHS Trust, leading impactful health initiatives. Dr Allwood holds advisory and academic positions at The King’s Fund, University of Cambridge, Mayo Clinic, and BMJ Leader Journal. As a Health Executive in Residence at GBSH, she contributes through guest lectures, mentoring, and curriculum development. Passionate about diversity and student engagement, she aims to establish internship opportunities and a Healthcare Innovation Lab.

Dr Minal Bakhai is the National Director for Primary Care and Community Transformation and Improvement at NHS England. She is a practicing GP, working at an inner-city London practice for over 12 years. Minal has a unique portfolio with experience stretching across national policy, strategy, industry, research and leadership of large-scale change and digital transformation. Additionally, she has been an expert advisor at NICE appraising the effectiveness of health technology. She is passionate about enabling high quality, sustainable primary and community services. Most recently enabling modern general practice and leading the national general practice improvement programme, which is evidence-led, data driven and deeply rooted in clinical practice – working in partnership with systems, PCNs, practices and communities to drive locally led transformation and improvement.

Danny Bosch is the Director of Business Development for South London and Maudsley FT NHS, where he leads commercial initiative to advance growth in the mental health sector. His role includes driving the Trust's approach to clinical innovation and ensuring that the NHS isn't a passive recipient of technology, but an active partner in innovation.

Previously, he served as Associate Director of Business Development and Commercial at Imperial College Health Partners, Commercial Director of Health Innovation Network and Commercial Lead of the London Secure Data Environment.  Here, he established a commercial skill centre and led initiatives using NHS data to foster collaborations and drive innovation. Before these roles, Danny held Management Consultant, Commercialisation Consultant and Research roles, specialising in technology transfer and value creation.

Danny holds a PhD in Biomedical Sciences from the University of Queensland and an Executive MBA with specialisation in Venture Creation and strategy from Warwick Business School. He is an experience mentor, start-up advisor, angel investor and passionate about fostering the next generation of leaders.

Silvia is an experienced leader with 18+ years operational and strategic experience in the Pharma and Consumer Goods industries with focus on innovation, data and analytics. 

She is currently Head of Transformation at Sanofi UK and Ireland where she leads a strategic initiatives in Data, AI and Digital Transformation.

Silvia is also a successful social entrepreneur. Since her daughter was diagnosed with an ultra rare eye disease leading to blindness, Silvia has been actively advocating for advancing treatments for inherited retinal dystrophies. She funded Eyes on the Future, a UK based charity, aiming to accelerate research for her daughter's disease. She leads the global patient organization catalyzing collaboration between academia, industry and patients. Her work led to several publications and, most importantly, concrete progress towards potential treatments. Her efforts have been featured in national and international press including BBC, Vanity Fair, London Evening Standard and Forbes. 

Silvia is extremely passionate about the role of innovation and data in transforming health care especially for patients with rare diseases. She is very excited about engaging with the next generation leaders at UCL Global Business School about the impact that business skills can make in health care and life science.

Mr Thian Chew is Chair & CEO of Invion Limited (ASX: IVX), an Australian clinical-stage life sciences firm transforming Photodynamic Therapy (PDT) into a novel and effective treatment for cancers and infectious diseases. He is also Co-Founder of Chronic Airway Therapeutics, a clinical-stage biotech firm focused on treating respiratory diseases.  Mr Chew is also Advisory Board Member at Stanford Medicine’s Center for Asian Health Research and Education (CARE).

Previously, Mr Chew was Managing Partner at Polar Ventures, an Executive Director at Goldman Sachs responsible for the firm’s proprietary investments, at Morgan Stanley’s Strategic Services Group and spent a decade with KPMG across Asia Pacific including leading business transformation and post-merger integration programs.

He is Adjunct Assoc Professor at Hong Kong Uni. of Science & Tech (Business, Life Sciences) and Visiting Professor at UCL Global Business School for Health.  Mr Chew holds an MBA from the Wharton School (Palmer Scholar) / MA (Lauder Institute), University of Pennsylvania. 

Omar is a seasoned healthcare executive and health-tech innovator with over 20 years of leadership experience spanning the UK, Middle East and South Asia. As Founder & Executive Chairman of 31G, Omar leads a health-tech venture delivering transformative digital solutions globally. He is also CEO and Executive Partner at Bourne Health, a London-based at-scale Primary Care organisation, where he continues to provide high-quality care delivery, M&A and strategic turnaround. In 2021, Omar played a pivotal role in the largest exit in UK Primary Care history, overseeing the integration of AT Medics into Centene Corp and driving operational transformation and improved EBITDA across Centene’s UK healthcare businesses.

With an MSc in Digital Health Leadership from Imperial College London and Harvard Medical School, as well as an MBA from the University of Surrey, Omar has spearheaded groundbreaking digital initiatives in healthcare. His projects include a UK leading virtual consultation platform, a nationally scaled Learning Management System, and an award-winning population health analytics platform. His special interest in research and life sciences has driven him to forge impactful commercial partnerships with the NIHR, Novo Nordisk, Novartis, CoreEvitas, the University of Oxford and others to enhance patient outcomes and care delivery.

In addition to his role at UCL, Omar serves as a Board Advisor to Nahdi Medical Company in Saudi Arabia and a strategic advisor for numerous health-tech and biotech ventures. He also supports UKDRI's Dementia Trials Accelerator, contributing to cutting-edge global dementia research. Omar’s work continues to shape the future of healthcare innovation and strategic leadership globally.

Dr Sheikh Mateen Ellahi is a GP Partner at Elmtree Medical Centre, one of the UK’s highest-rated practices. He leads patient care and drives operational improvements, specializing in clinical governance and transforming practices to CQC compliance. As a GP and Advanced Clinical Practitioner Trainer, he mentors future healthcare professionals and heads Primary Care Network teaching initiatives. Dr Ellahi also serves as a Private GP, focusing on personalized care, and is an Honorary Lecturer at UCL, where he brings primary care leadership insights to the MBA in Global Health program.

MaryAnn is the Chief Medical Officer for Health Innovation Kent Surrey Sussex and a Non-Executive Director for Kent and Medway NHS Partnership Trust and Kent Community Health Foundation Trust. She has 20 years’ experience working across both the Australian and UK health system, with specialist qualifications in health system leadership, management, and population health.

She has held Board level roles as a medical leader in both primary and secondary care and is passionate about using digital and innovation to improve the patient experience for underserved communities, deliver better integration, and ensure equitable access to care. She is a thought leader for health equity in innovation and is leading on several projects to explore gender and racial bias in AI, debias policymaking and increase women in leadership for digital and technology.

She has a special interest in researching health equity and the impact of the social determinants of health, and she is leading several initiatives to promote equity, diversity and inclusion in medicine with the Royal College of Physicians (Edinburgh). MaryAnn is committed to using her position to role-model an inclusive leadership approach whereby she supports, mentors and coaches, people from disadvantaged backgrounds to widen participation in medicine and increase diversity within healthcare leadership.

Chris is a Director in KPMG’s Digital Health Practice bringing 12 years of experience in Health Technology across national and local provider engagements.

Chris sits on the Board of a VCSE Mental Health Provider delivering IAPT services across England and specialist services in the North East. Chris has led on digital strategy, road-mapping and large-scale delivery engagement for several national services including ERP, digital workplace, cyber security, and infrastructure services. His experience at local level has focused on Clinical Systems Transformation and Digital Strategy development.

Nabeel Goheer is a seasoned leader with more than 25 years of professional experience in systemic transformation, symbiotic partnerships, and interoperable development. Presently, he is working as the Chief/Vice President of PATH, an American non-profit specializing in biotech and global public health. He is based at London and in charge of Asia, Middle East, and European operations.

Before this role, he provided leadership at the Commonwealth, an intergovernmental association of 56 countries representing 2.6 billion people, and supervised strategy, governance, technology, innovation, and digitalization departments as an Assistant Secretary-General. Earlier, he worked with the United Nations system, the World Bank, USAID, and the Government of Pakistan. Nabeel holds a PhD from Judge Business School, University of Cambridge.

He is serving on the Boards of Royal Overseas League, International School of Government at Kings College London, Middlesex University and Foundation of Appropriate Technologies in Health of Switzerland. He is a member of MIT Equitable Health Systems Challenge Leadership Group, runs a leadership program at the UN System Staff College and serves as a Health Executive in Residence at the UCL Global Business School for Health. Additionally, Nabeel is actively engaged in global governance discussions, participating in the World Economic Forum’s working group on AI governance.

Toby Goldblatt is a serial founder and corporate tech executive with specialisms in AI and Health & Life Sciences. He has built leading global organisations such as Accenture / Avanade; Eviden; CACI working with clients including NHS Digital, Blood & Transplant; World Health Organisation; Governments in Spain; Norway; UAE and India plus a range of Life Science & Digital Health companies.

In 2021 he founded and then subsequently sold Pivot Digital Health a groundbreaking digital technology, AI and advisory service provider. Today he runs Renew, focused on scaling up companies in the Digital Health, Tech industries in collaboration with Private Equity and Academia. In the past he has supported and mentored UCL GBSH alumni in experiencing what life as a founder is like. He has not for profit programs running around undiagnosed patients (Project Equal); Ethical AI (Project Human) and has specialisms in Synthetic data and Agentic solutions for Healthcare.

Joanne M. Hackett is Vice President and Head of Health System Services at IQVIA and previously was the Chief Commercial Officer at Genomics England.

Dr Hackett is a clinical academic, entrepreneur, investor, and a strategic, creative visionair with global experience spanning successful start-ups to Fortune 500 companies. Aside from her curious passion for life and positivity, Joanne is known for building innovation, driving personalised medicine and leading through fast paced, complex changing ecosystems and integrations. Joanne's goal is to contribute to bringing the world novel, cost effective and simple health care solutions, and she is particularly keen on building the case for prevention, open science and citizen genomics. She has extensive global experience across academic, business and clinical institutions, and enjoys sharing her experiences with the Boards she sits on as well as companies she provides strategic advice to. 

Joanne has been publicly recognised for her relentless pursuit of revolutionising healthcare and has been named one of the top six Influential Leaders in Healthcare by CIO Look, the Accenture Life Science Leader of the year, Freshfields Top 100 Most Influential Women, One HealthTech Top 70 Women in the NHS, Pharmaceutical Market Europe’s 30 women leaders in UK healthcare and BioBeat Top 50 Women in Biotech Award. Joanne believes in human courage and perseverance against the odds, and demonstrates that positive change, whether in a company or in one’s personal life, can be carved out from even the greatest of trials. As a believer of ‘health = wealth’, Joanne is an internationally known yoga instructor.

Andreas is currently Managing Director, Healthcare UK at Accenture with a mission to help the NHS and health and care Industry reinvent how care is delivered - enabled by Automation, Data, AI and other digital technologies.

Examples of his work include engagements with Alder Hey Children’s Hospital and NHS B&T to improve patient and donor experience. To Improve health outcomes more broadly Andreas is currently collaborating with health systems across Leeds and London to deploy Data and AI/LLM capabilities to understand early signs of disease and take preventative measures, including Digital Therapeutics.

Andreas is a Non-Executive Director in the NHS, Health Executive in Residence with UCL, Member of the Advisory Board for the ShuriNetwork and previous Chair of the Health and Social Care (HSC) Council, dechunk.

Dr Zaeem Haq is a global health and development leader with extensive experience in health policy, program management and governance globally. He has lived or worked in over 20 countries with organisations such as Save the Children, Médecins Sans Frontières, International Rescue Committee, Malaria Consortium and the Aga Khan Foundation.

He is currently the Global Director of Medical Services and Regulated Programs at Save the Children International, providing strategic leadership and oversight on global programs involving clinical and pharmacy services, digital health and innovation, construction and environmental sustainability. In this role, he ensures effective program operations, quality assurance, risk management, incident management, regulatory compliance, and staff health and wellbeing globally. 

In addition, he is a Non-Executive Director at the North East London NHS Foundation Trust, member of the Great Ormond Street Hospital NHS Foundation Trust, member of the Global Child Health Taskforce, fellow at the Royal Society of Public Health, and a post-grad research supervisor at the London School of Economics International Health Policy programme. In past, he has been a Board member at the Norfolk Community Health & Care NHS Trust and the British Refugee Council for over 5 years.

Zaeem trained as a medical doctor in Pakistan and specialised in community medicine and public health, and has studied health policy and management at Johns Hopkins Bloomberg School of Public Health, health economics at the London School of Hygiene and Tropical Medicine, global health security at the Geneva Centre for Security Policy, and completed the Executive Leadership Programme at the Oxford University Saïd Business School.

Dr Linda Harris OBE FRCGP (GMC 3342112) is the Founding Chief Executive of Spectrum Community Health CIC, which provides healthcare for vulnerable populations, including primary care, substance misuse, and sexual health services across North England in community and secure environments. A former GP and Clinical Director for Integrated Substance Misuse in Wakefield, Linda has a special interest in substance misuse, having founded Spectrum in 2011. She is also the Executive Chair of SLD Training, which offers RCGP-accredited programs in substance misuse management.

Dr Harris has held leadership roles in NHS England's Health and Justice Clinical Reference Group and is a trustee of Spectrum People charity. She received an OBE in 2021 for her services to the NHS.

Dr Dimitrios Kalogeropoulos is the Chief Executive of the Global Health & Digital Innovation Foundation, with over 30 years of experience in AI and personalised medicine. A trusted advisor to organizations like the WHO and World Bank, he promotes digital health governance and innovation ecosystems. He leads global initiatives, including the IEEE P3493.1 Standard for secure healthcare data recycling. His work spans policy, AI ethics, and digital health transformation, and he is a sought-after speaker on healthcare innovation worldwide.

Dr Raees Lunat is a practicing doctor who has held a range of leadership positions within the NHS, industry and the private sector.

He has served as Senior Advisor to 3 members of NHS England's Executive Committee including the Chief Workforce Officer and Chief People Officer of the NHS. His remit at the time involved provided providing strategy, policy and clinical input into work relating the NHS Workforce, this includes areas such as workforce planning, staff experience, leadership and the NHS’ first long term workforce plan. He has also served as Chief Medical Information Officer at a greater London Trust where he supported the roll out of electronic records and implemented digital solutions to improve clinical productivity and patient care.

Raees also has Industry experience as PwC and Strategy& UK’s Clinical Lead and Clinical Safety Officer. In this role he leads on clinical strategy, clinical model redesign and digital transformation for a range of healthcare providers, commissioners and Governments. Dr Lunat is passionate about using his clinical work and wider experiences to bring meaningful change to patients.

Don McDaniel is a healthcare leader and entrepreneur with over 25 years of experience, specializing in innovation and disruption across the healthcare sector. He has founded and led several healthcare companies, including Canton & Company and Sage Growth Partners, and held executive roles in hospitals, health services, and insurance. Don advises and invests in disruptive healthcare firms, helping them succeed in the evolving health economy.

A sought-after speaker and thought leader, he has delivered keynote addresses at major industry events and taught health economics at prestigious universities, including Johns Hopkins. He is also the inaugural Health Executive in Residence at UCL Global School for Health. Don is passionate about reshaping healthcare through market-driven innovation.

Johanna Moss was appointed to the UCLH Board on 7 January 2025 as the director of strategy. Prior to this Jo was the chief strategy and transformation officer for the North East London Integrated Care Board and she also held the role of director of strategy and partnerships at Moorfields Eye Hospital NHS Foundation Trust for seven years, where she was the lead for their major capital project to build a new hospital and research centre in Camden.

Jo has prior experience of UCLH, having been a divisional manager and deputy director of strategic development, and is rejoining the Trust to lead on the implementation of a number of key strategic projects.

After graduating from Leeds University, Ben joined Pfizer in 1998, where his career has taken him through a variety of leadership roles both in the UK and internationally.

Ben is the President, International Commercial Office at Pfizer Inc where he is responsible for the commercial and marketing organisations across the 140 countries that Pfizer operate in outside of the US.  He is passionate about organisational culture and purpose to ensure patients benefit from breakthrough innovation and science. Ben was the UK Country Manager and Managing Director for Pfizer UK from 2019 - 2022, leading the organisation through unprecedented times of opportunity to bring science, data, and technology together to transform healthcare. He led the UK roll out of Pfizer’s work to overcome Covid, working closely with government and the NHS during an unprecedented period of our times.

From May 2021 to May 2022, Ben was President of the Association of the British Pharmaceutical Industry, Ben has also represented the life science industry on a number of committees with government and NHS. He is also an advisory board member for the EU HBA organisation.

Dr Jing Ouyang is a doctor, health tech executive, board advisor and published academic with a passion for healthcare innovation and technology. He co-founded Patchwork Health, a pioneer in flexible workforce management solutions in healthcare that works with over 100 NHS Trusts. He co-hosts the Out of Programme podcast, which explore the personal journeys of clinicians who take unconventional career paths. In addition, he is a healthcare startup mentor for Baltic Ventures and the NHSE Clinician Entrepreneur Programme.

Minesh Parbat, FRPharmS MPharm(Hons), ClinDip, IPresc, MSc has worked in senior leadership positions within the NHS and has led on medicines optimisation projects both strategically and operationally. He is currently ICS Chief Pharmacist, NHS Shropshire, Telford and Wrekin ICB and has a keen interest in organisational development and collaborative working.

Minesh practiced as an independent prescribing pharmacist in long term conditions clinics and structured medication reviews in GP Practice for over 10 years. Minesh has supported various academic institutions as a visiting lecturer to engage students in research projects and audit initiatives. He has served on a numbers of national and local pharmacy related committees to support the progression of the pharmacy profession and has a keen interest in leadership, equality, diversity and inclusion across various healthcare professions.

Lloyd is a HealthTech Founder, Consumer Internet Executive, Portfolio Non-Executive Director and M&A Advisor with 25 years of experience founding and funding, scaling and exiting businesses.

He co-founded Zesty in June 2012, building the company through multiple investment rounds from leading European & US Venture Capital funds into an award-winning UK Digital Health company and sale to Induction Healthcare Group PLC in May 2020. (FTSE AIM: INHC) 

Lloyd was a founding member of the Digital Healthcare Council in 2017 and Board Member for the Coalition for a Digital Economy conducting two trade delegation visits to the European Parliament in 2015 and 2016. 

He is a Non-Executive Director for a Portfolio of leading UK Digital Health companies, ranging from Digital MSK to urgent care workforce management to NHS spinouts pioneering healthcare innovation across the UK and Asynchronous TeleHealth.
 
Lloyd has worked with Cambridge Judge Business School judging MBA students Digital Health projects and regularly mentors students from both the Oxford University Venture Capital Network and Oxford MedTech Society.

He founded Nelson Advisors in 2021 focused on Healthcare Technology Merger & Acquisitions, Growth & Strategy projects. Nelson Advisors work with founders, owners, boards & investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value.

Tiba’s background in sales and training with Eli Lilly and change management consultancy with Accenture has helped shape the services and solutions that Soar Beyond innovates to overcome resistance to change and transformation in the health system, particularly related to medicines. Soar Beyond is now an established digital health provider consultancy with an extensive client base of both NHS and pharmaceutical companies.  

Tiba leads on both the innovation and commercialisation of pioneering solutions that meet the needs of the clinical and non-clinical workforce in the NHS. She is passionate about identifying health system gaps and boldly inventing simple, intuitive solutions and methodologies that address these.   

The SMART workforce and i2i Network digital solutions are commissioned nationally by NHS England and global pharmaceutical companies and have been recognised for their innovative nature by NHS Accelerator programmes. Tiba was identified as a ‘One to Watch’ on the LDC and The Times's Top 50 most ambitious leaders in 2022.

Dr Anthony Renshaw acts as chief medical officer to numerous global organisations, advising on public health, remote healthcare, crisis management, pandemic planning and corporate health.  Since joining International SOS in 2008, he has consulted widely across Europe, Africa and Asia-Pacific, and has overseen health service delivery platforms in both remote and urban health settings across the world including China, Mongolia, Russia, Korea, Japan, Australia and Papua New Guinea, working across a range of industrial clients and government agencies from prisons to defence. Through this, he has developed a keen interest in the complex interplay between global health and the private sector. 

Prior to International SOS, Anthony worked as a surgeon in the UK and South Africa. He is a Founding Fellow of the Faculty of Medical Leadership and Management, and a Fellow of the Royal Society for Public Health. He is a Member of the Royal College of Surgeons of Edinburgh, where he is an Fellow and Advisory Board Member of the Faculty of Rural, Remote and Humanitarian Healthcare. 

Anthony holds an Executive MBA from INSEAD in Fontainebleau and read medicine at the University of Manchester, where he also holds bachelor degrees in immunology and oncology.  He holds a doctorate in surgery from UCL, where he is a Health Executive-in Residence at the UCL Global Business School for Health.

Rubén is the Executive Director and founding partner of Fractal EDM, a company dedicated to applying health economics concepts to inform and support public policy. Rubén's main goal is to demonstrate that it is possible to achieve better health outcomes at a lower cost for the system.

He specialised in health economics at the University of York, United Kingdom, where he earned a Master of Science degree in Economic Evaluation for Health Technology Assessment.

His postgraduate specializations include biostatistics, clinical epidemiology, and Outcomes Research from Harvard School of Public Health, USA. Additionally, he holds postgraduate specialisations in Value-Based Health Care and Behavioral Economics from Harvard Business School, USA.

In his professional roles, Rubén has served as an Advisor to the Minister of Health (2018-2019) and as a member of the Presidential Health Reform Commission during the same period.

Vincent Sai is a highly accomplished healthcare leader with over 25 years of experience in primary care and large-scale transformation. As Group CEO and Partner of Modality Partnership, he has expanded its reach to over 11 million citizens across the UK.

A Chartered Accountant and Honorary Fellow of the Royal College of General Practitioners, Vincent is the only non-clinical partner among 130 GPs. He also leads Pathfinder Healthcare Developments CIC and sits on the boards of biotech and health tech startups. Vincent is a Visiting Associate Professor of Practice at UCL’s Global Business School for Health.

Seasoned and visionary Chief Executive Officer with over two decades of progressive leadership experience in the healthcare technology sector and broader business landscape. Demonstrates an exceptional ability to lead complex organisations across diverse geographic regions, including the UK, EMEA, Australia, and Canada. Widely recognised for delivering measurable results in high-growth environments, with a consistent track record of exceeding revenue targets, optimising operations, and leading large-scale transformations.

Expert in end-to-end business leadership, including full P&L ownership, strategic planning, corporate governance, and post-merger integration. Adept at identifying high-value acquisition opportunities, executing due diligence, and driving integration strategies that align with long-term business objectives and shareholder value. Trusted advisor to boards and executive teams, with a reputation for aligning vision with execution, cultivating high-performance cultures, and guiding organisations through periods of both growth and change.

Former Senior Non-Commissioned Officer in the British Army, bringing forward-tested leadership skills, operational discipline, and an innate ability to thrive under pressure. Decorated for outstanding service and leadership in dynamic, high-stakes environments. This foundation underpins a unique executive presence—calm, decisive, and accountable.

Graduated from the prestigious Senior Executive Programme at Hult Ashridge in 2017, enhancing strategic decision-making, innovation, and global leadership capabilities. Known for a people-centric approach, fostering collaborative environments that unlock individual and collective potential.

Sara is Deloitte’s Global healthcare sector Leader and leads the health practice in the UK.  This encapsulates the firm’s work with the payor and provider systems both publicly and privately funded.  Sara’s passion for health began when she moved to the UK in 2003 and was first exposed to the NHS.

Sara believes passionately in the mission of the NHS and sees the incredible value that a health service free at the point of need provides to society.  With her teams, she supports the NHS to do more and better with the resources at its disposal.  Some of Sara’s work includes supporting the government on its Coronavirus testing programme, and the introduction of robotic and cognitive automation to improve the speed and quality of NHS services and to release more time for direct patient care.  It is the introduction and uptake of new innovative practices either pioneered by individuals or tested first in other health systems around the world that Sara most enjoys working with her NHS clients on.

In her global role, Sara works to create connectivity between the health systems of the world all seeking to solve similar challenges.  The practice supports healthcare clients with digital implementations, cyber security, data analytics, care pathway redesign, workforce improvements, virtual care and increasingly AI and GenerativeAI solutions to the wicked issues affecting healthcare.

Sara is a trustee of the Peter Sowerby Foundation which supports healthcare causes and she is a trustee of Helpforce which supports volunteering in the NHS.

A career health business executive, Adrian has a huge depth of knowledge and experience in the design, commissioning, funding, operation management and governance of complex multidisciplinary projects. With over 32 years of experience driving private healthcare innovation in the UK and advising in international markets, he brings insight, prescience and the ability to proactively manage multifaceted stakeholder relationships.

Adrian is founder and CEO of Independent Care, delivering state of the art medical facilities across the UK. He is one of the most experienced developers and operational directors of private hospitals, mixed use diagnostic facilities and primary care centres in the UK.

He co-founded one of the leading private GP companies in the City of London and has also built a successful consultancy company advising the NHS and supporting investors and operators in international healthcare markets. As a Board member of IHPN, the Independent Healthcare Providers Network, he was a key influencer working with Central Government, the NHS, and other key stakeholders including the GMC and BMA in all aspects of governance and policy with implications for the sector.

Ming Tang is the Chief Data and Analytics Officer (CDAO) for NHS England, where she oversees data and analytics services and leads transformation programs with a team of approximately 1,700 FTEs. Her role includes the development and delivery of advanced data platforms and decision-support tools to improve operational efficiency and support healthcare recovery initiatives. Ming played a pivotal role in the COVID-19 pandemic response, managing data science, analysis, and the national vaccination service.

Previously, she served as the Managing Director of NHS South Yorkshire and Bassetlaw Commissioning Support Unit and Director of Healthcare Commissioning Services for the West Midlands. Before her healthcare roles, Ming spent over a decade at Accenture, leading the Supply Chain Practice in Southeast Asia, and held key operational roles at GlaxoSmithKline, specializing in logistics and new product planning.

Ming is a qualified executive coach, experienced mentor, and has a passion for knowledge-sharing through teaching and research. She envisions contributing to GBSH through guest lectures, mentoring, and exploring AI and digital innovation in healthcare.